Literature DB >> 12767833

The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.

Mohammed Aslam1, Joel M Guthridge, Bradley K Hack, Richard J Quigg, V Michael Holers, Stephen J Perkins.   

Abstract

Complement receptor-related gene/protein y (Crry) is a cell membrane-bound regulator of complement activation found in mouse and rat. Crry contains only short complement/consensus repeat (SCR) domains. X-ray and neutron scattering was performed on recombinant rat Crry containing the first five SCR domains (rCrry) and mouse Crry with five SCR domains conjugated to the Fc fragment of mouse IgG1 (mCrry-Ig) in order to determine their solution structures at medium resolution. The radius of gyration R(G) of rCrry was determined to be 4.9-5.0 nm, and the R(G) of the cross-section was 1.2-1.5 nm as determined by X-ray and neutron scattering. The R(G) of mCrry-Ig was 6.6-6.7 nm, and the R(G) of the cross-section were 2.3-2.4 nm and 1.3 nm. The maximum dimension of rCrry was 18 nm and that for mCrry-Ig was 26 nm. The neutron data indicated that rCrry and mCrry-Ig have molecular mass values of 45,000 Da and 140,000 Da, respectively, in agreement with their sequences, and sedimentation equilibrium data supported these determinations. Time-derivative velocity experiments gave sedimentation coefficients of 2.4S for rCrry and 5.4S for mCrry-Ig. A medium-resolution model of rCrry was determined using homology models that were constructed for the first five SCR domains of Crry from known crystal and NMR structures, and linked by randomly generated linker peptide conformations. These trial-and-error calculations revealed a small family of extended rCrry structures that best accounted for the scattering and ultracentrifugation data. These were shorter than the most extended rCrry models as the result of minor bends in the inter-SCR orientations. The mCrry-Ig solution data were modelled starting from a fixed structure for rCrry and the crystal structure of mouse IgG1, and was based on conformational searches of the hinge peptide joining the mCrry and Fc fragments. The best-fit models showed that the two mCrry antennae in mCrry-Ig were extended from the Fc fragment. No preferred orientation of the antennae was identified, and this indicated that the accessibility of the antennae for the molecular targets C4b and C3b was not affected by the covalent link to Fc. A structural comparison between Crry and complement receptor type 1 indicated that the domain arrangement of Crry SCR 1-3 is as extended as that of the CR1 SCR 15-17 NMR structure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767833     DOI: 10.1016/s0022-2836(03)00492-3

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Constrained solution scattering modelling of human antibodies and complement proteins reveals novel biological insights.

Authors:  Stephen J Perkins; Azubuike I Okemefuna; Ruodan Nan; Keying Li; Alexandra Bonner
Journal:  J R Soc Interface       Date:  2009-07-15       Impact factor: 4.118

2.  Complement factor H deficiency accelerates development of lupus nephritis.

Authors:  Lihua Bao; Mark Haas; Richard J Quigg
Journal:  J Am Soc Nephrol       Date:  2010-12-09       Impact factor: 10.121

3.  Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

Authors:  Carl Atkinson; Hongbin Song; Bo Lu; Fei Qiao; Tara A Burns; V Michael Holers; George C Tsokos; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

4.  Structure and flexibility within proteins as identified through small angle X-ray scattering.

Authors:  Martin Pelikan; Greg L Hura; Michal Hammel
Journal:  Gen Physiol Biophys       Date:  2009-06       Impact factor: 1.512

5.  An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.

Authors:  Svetlana N Tchepeleva; Joshua M Thurman; Katherine Ruff; Stephen J Perkins; Laurence Morel; Susan A Boackle
Journal:  J Immunol       Date:  2010-07-21       Impact factor: 5.422

Review 6.  Complement regulation in renal disease models.

Authors:  Abhijit Naik; Shweta Sharma; Richard J Quigg
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

7.  Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.

Authors:  Yanling Lu; Stephen E Harding; Terje E Michaelsen; Emma Longman; Kenneth G Davis; Alvaro Ortega; J Günter Grossmann; Inger Sandlie; José García de la Torre
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

8.  Crystallohydrodynamics of protein assemblies: Combining sedimentation, viscometry, and x-ray scattering.

Authors:  Yanling Lu; Emma Longman; Kenneth G Davis; Alvaro Ortega; J Günter Grossmann; Terje E Michaelsen; José García de la Torre; Stephen E Harding
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

9.  Structures of the rat complement regulator CrrY.

Authors:  Pietro Roversi; Steven Johnson; Joseph J E Caesar; Florence McLean; Kirstin J Leath; Stefanos A Tsiftsoglou; B Paul Morgan; Claire L Harris; Robert B Sim; Susan M Lea
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-06-23

10.  Near-planar solution structures of mannose-binding lectin oligomers provide insight on activation of lectin pathway of complement.

Authors:  Ami Miller; Anna Phillips; Jayesh Gor; Russell Wallis; Stephen J Perkins
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.